These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19307544)

  • 1. Do the unintended actions of botulinum toxin at distant sites have clinical implications?
    Currà A; Berardelli A
    Neurology; 2009 Mar; 72(12):1095-9. PubMed ID: 19307544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological changes after intramuscular injection of botulinum toxin.
    Palomar FJ; Mir P
    Clin Neurophysiol; 2012 Jan; 123(1):54-60. PubMed ID: 22051548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?
    Caleo M; Antonucci F; Restani L; Mazzocchio R
    J Neurochem; 2009 Apr; 109(1):15-24. PubMed ID: 19154335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of botulinum toxin type A: evidence and supposition.
    Currà A; Trompetto C; Abbruzzese G; Berardelli A
    Mov Disord; 2004 Mar; 19 Suppl 8():S60-4. PubMed ID: 15027056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin: mechanisms of action.
    Dressler D; Adib Saberi F
    Eur Neurol; 2005; 53(1):3-9. PubMed ID: 15650306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2008 Oct; 7(10):1006-7. PubMed ID: 19112770
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.
    Dressler D
    Mov Disord; 2004 Mar; 19 Suppl 8():S92-S100. PubMed ID: 15027060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin type A and cholinergic system].
    Bach-Rojecky L; Relja M; Filipović B; Lacković Z
    Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of axoplasm synthesis disorders in the nerve cell in lesions of the peripheral neuromuscular apparatus induced by botulinum toxin].
    Mikhaĭlov VV; Denisova DA
    Biull Eksp Biol Med; 1966 Nov; 31(11):44-7. PubMed ID: 4194255
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulinum toxin: mechanisms of action.
    Dressler D; Saberi FA; Barbosa ER
    Arq Neuropsiquiatr; 2005 Mar; 63(1):180-5. PubMed ID: 15830090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of systemic handling in the pathophysiologic actions of botulinum toxin.
    Al-Saleem FH; Ancharski DM; Ravichandran E; Joshi SG; Singh AK; Gong Y; Simpson LL
    J Pharmacol Exp Ther; 2008 Sep; 326(3):856-63. PubMed ID: 18539649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin: from drug to poison].
    Dressler D; Saberi FA
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S49-54. PubMed ID: 19685394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and retrograde axonal transport of horseradish peroxidase in botulinum-intoxicated mice.
    Kristensson K; Olsson T
    Brain Res; 1978 Oct; 155(1):118-23. PubMed ID: 80253
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum toxin drugs: brief history and outlook.
    Dressler D
    J Neural Transm (Vienna); 2016 Mar; 123(3):277-9. PubMed ID: 26559824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct central nervous system effects of botulinum neurotoxin.
    Caleo M; Restani L
    Toxicon; 2018 Jun; 147():68-72. PubMed ID: 29111119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurospecific binding, internalization, and retrograde axonal transport.
    Halpern JL; Neale EA
    Curr Top Microbiol Immunol; 1995; 195():221-41. PubMed ID: 8542755
    [No Abstract]   [Full Text] [Related]  

  • 18. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytophotometric quantification of retrograde axonal transport of a fluorescent tracer (primuline) in mouse facial neurons.
    Enerbäck L; Kristensson K; Olsson T
    Brain Res; 1980 Mar; 186(1):21-32. PubMed ID: 6153553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief history of neurological botulinum toxin therapy in Germany.
    Dressler D; Roggenkaemper P
    J Neural Transm (Vienna); 2017 Oct; 124(10):1217-1221. PubMed ID: 28733711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.